Hypertension and the risk of mild cognitive impairment
- PMID: 18071036
- PMCID: PMC2672564
- DOI: 10.1001/archneur.64.12.1734
Hypertension and the risk of mild cognitive impairment
Abstract
Objective: To explore whether hypertension is associated with the risk of mild cognitive impairment (MCI), an intermediate stage of dementia, because there are conflicting data relating hypertension to the risk of Alzheimer disease.
Design and setting: Prospective community-based cohort study conducted in northern Manhattan. Multivariate proportional hazards regression analyses were used, relating hypertension to incident all-cause MCI, amnestic MCI, and nonamnestic MCI in 918 persons without prevalent MCI at baseline followed up for a mean of 4.7 years.
Results: There were 334 cases of incident MCI, 160 cases of amnestic MCI, and 174 cases of nonamnestic MCI during 4337 person-years of follow-up. Hypertension was associated with an increased risk of all-cause MCI (hazard ratio, 1.40; 95% confidence interval, 1.06-1.77; P = .02) and nonamnestic MCI (hazard ratio, 1.70; 95% confidence interval, 1.13-2.42; P = .009) after adjusting for age and sex. Both associations were slightly attenuated in models additionally adjusting for stroke and other vascular risk factors. There was no association between hypertension and the risk of amnestic MCI (hazard ratio, 1.10; 95% confidence interval, 0.79-1.63; P = .49). Consistent with this association, hypertension was related with the slope of change in an executive ability score, but not with memory or language score. There was no effect modification of the association between hypertension and MCI by APOEepsilon4 genotype or use of antihypertensive medication.
Conclusions: A history of hypertension is related to a higher risk of MCI. The association seems to be stronger with the nonamnestic than the amnestic type of MCI in the elderly. These findings suggest that prevention and treatment of hypertension may have an important impact in lowering the risk of cognitive impairment.
Comment in
-
Hypertension and mild cognitive impairment subtypes.Arch Neurol. 2008 Jul;65(7):992-3; author reply 994-5. doi: 10.1001/archneur.65.7.992-c. Arch Neurol. 2008. PMID: 18625877 No abstract available.
-
Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease.Arch Neurol. 2008 Jul;65(7):993-4; author reply 994-5. doi: 10.1001/archneur.65.7.993. Arch Neurol. 2008. PMID: 18625880 No abstract available.
References
-
- Bischkopf J, Busse A, Angermeyer M. Mild cognitive impairment - a review of prevalence, incidence, and outcome according to current approaches. Acta Psychiatr Scand. 2002;106:403–414. Ref Type: Journal (Full) - PubMed
-
- Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001 December;58(12):1985–92. - PubMed
-
- Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001 May 8;56(9):1133–42. - PubMed
-
- Larrieu S, Letenneur L, Orgogozo JM, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002 November 26;59(10):1594–9. - PubMed
-
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999 March;56(3):303–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical